RWIFX
Price
$68.73
Change
-$0.74 (-1.07%)
Updated
Jun 13 closing price
Net Assets
131.04B
VESGX
Price
$47.02
Change
-$0.81 (-1.69%)
Updated
Jun 13 closing price
Net Assets
1.43B
Interact to see
Advertisement

RWIFX vs VESGX

Header iconRWIFX vs VESGX Comparison
Open Charts RWIFX vs VESGXBanner chart's image
American Funds Capital World Gr&Inc R5
Price$68.73
Change-$0.74 (-1.07%)
VolumeN/A
Net Assets131.04B
Vanguard Global ESG Select Stk Admiral
Price$47.02
Change-$0.81 (-1.69%)
VolumeN/A
Net Assets1.43B
RWIFX vs VESGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RWIFX vs. VESGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIFX is a Buy and VESGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIFX has more cash in the bank: 131B vs. VESGX (1.43B). RWIFX pays higher dividends than VESGX: RWIFX (1.80) vs VESGX (1.61). RWIFX was incepted earlier than VESGX: RWIFX (23 years) vs VESGX (6 years). VESGX (0.48) and RWIFX (0.46) have similar cost to investors . VESGX is a more actively managed with annual turnover of: 33.00 vs. RWIFX (27.00). RWIFX has a lower initial minimum investment than VESGX: RWIFX (250) vs VESGX (50000). VESGX (6.70) and RWIFX (6.65) have marching annual gain over last year. VESGX return over 5 years is better than : 76.83 vs. RWIFX (53.30).
RWIFXVESGXRWIFX / VESGX
Total Expense Ratio0.460.4896%
Annual Report Gross Expense Ratio0.460.4896%
Fund Existence23 years6 years-
Gain YTD9.1634.373210%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets131B1.43B9,135%
Annual Yield % from dividends1.801.61112%
Returns for 1 year6.656.7099%
Returns for 3 years45.1244.09102%
Returns for 5 years53.3076.8369%
Returns for 10 years53.59N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VYNE0.900.01
+1.08%
VYNE Therapeutics
GHRS12.76-0.07
-0.55%
GH Research PLC
HASI27.02-0.23
-0.84%
HA Sustainable Infrastructure Capital Inc.
LPLA374.08-5.31
-1.40%
LPL Financial Holdings
INMB7.70-0.22
-2.78%
INmune Bio